Muir-Torre Syndrome: A Rare Case Report and Review of Literature
Open Access
- 1 March 2026
- journal article
- case report
- Published by Taylor & Francis in Clinical, Cosmetic and Investigational Dermatology
- Vol. ume 19, 1-6
Abstract
Muir-Torre syndrome (MTS) is an uncommon autosomal dominant disorder characterized by germline mutations in DNA mismatch repair (MMR) genes, resulting in microsatellite instability (MSI). It is regarded as a variant form of Lynch syndrome, characterized by the co-occurrence of at least one cutaneous sebaceous neoplasm and at least one visceral malignancy. Furthermore, studies have indicated that MTS may manifest in transplant recipients and in immunocompromised patients. The diagnosis and management of such cases necessitate a multidisciplinary approach. Here, we report a case of a Chinese patient with a history of rectal cancer who developed multiple sebaceous adenomas during immunosuppressive therapy six years after renal transplantation. This case report not only provides additional evidence for the inducing effect of immunosuppressants on MTS but also emphasizes the importance of a thorough diagnosis of MTS and the significance of preventing the development of potential skin tumors in patients with MTS.Keywords
This publication has 19 references indexed in Scilit:
- Muir–Torre Syndrome: A Cutaneous Finding Amidst Broader MalignanciesAmerican Journal of Clinical Dermatology, 2023
- Sebaceous neoplasms and the immunoprofile of mismatch-repair proteins as a screening target for syndromic casesPathology - Research and Practice, 2015
- A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir–Torre variant of Lynch syndromeGenetics in Medicine, 2014
- Muir–Torre syndrome or phenocopy? The value of the immunohistochemical expression of mismatch repair proteins in sebaceous tumors of immunocompromised patientsFamilial Cancer, 2014
- Estudio de inestabilidad de microsatélites y genético de los pacientes con síndrome de Muir-TorreActas Dermo-Sifiliograficas, 2013
- Immunosuppression and sebaceous tumors: A confirmed diagnosis of Muir-Torre syndrome unmasked by immunosuppressive therapyJournal of the American Academy of Dermatology, 2011
- MSH-6: extending the reliability of immunohistochemistry as a screening tool in Muir–Torre syndromeLaboratory Investigation, 2008
- Muir-Torre syndromeThe Lancet Oncology, 2005
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancerNature Reviews Cancer, 2002
- Association of sebaceous gland tumors and internal malignancy: The muir-torre syndromeThe American Journal of Medicine, 1991